| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 34.8 | 124.19 | 128.03 | 146.24 | 202.96 |
| Other Income | 1.39 | 1.18 | 1.39 | 0.73 | 6.01 |
| Stock Adjustments | 0 | -19.14 | 6.56 | 3.41 | -15.27 |
| Total Income | 36.19 | 106.23 | 135.98 | 150.38 | 193.7 |
| EXPENDITURE : | |||||
| Raw Materials | 26.97 | 70.72 | 112.93 | 114.44 | 151.05 |
| Excise Duty | 0 | 0 | 0 | 0.02 | 0.21 |
| Power and Fuel Cost | 1.24 | 1.66 | 2.23 | 2.21 | 1.81 |
| Other Manufacturing Expenses | 0.62 | 0.79 | 10.86 | 13.22 | 1.79 |
| Employee Cost | 10.31 | 10.21 | 10.03 | 9.61 | 11.42 |
| Selling and Administration Expenses | 3.57 | 8.81 | 2.42 | 2.2 | 2.07 |
| Miscellaneous Expenses | 0.02 | 0.04 | 0.14 | 4.55 | 7.27 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -6.54 | 14.01 | -2.62 | 4.14 | 18.08 |
| Interest and Financial Charges | 1.01 | 4.21 | 5.69 | 1.13 | 6.03 |
| Profit before Depreciation and Tax | -7.55 | 9.8 | -8.31 | 3.01 | 12.05 |
| Depreciation | 0.41 | 0.58 | 0.65 | 0.91 | 1.04 |
| Profit Before Tax | -7.96 | 9.22 | -8.96 | 2.1 | 11.01 |
| Tax | -3.7 | 2.71 | -2.75 | 0.55 | 4.6 |
| Profit After Tax | -4.26 | 6.51 | -6.21 | 1.55 | 6.41 |
| Adjustment below Net Profit | 0.01 | 0.14 | 0 | 0 | 0 |
| P and L Balance brought forward | -1.43 | -8.08 | -1.87 | -3.41 | -9.82 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -5.69 | -1.43 | -8.07 | -1.87 | -3.41 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 1.51 | 0 | 0.36 | 1.48 |
| Book Value | 8.68 | 9.67 | 8.13 | 9.57 | 9.21 |
| Extraordinary Items | 0 | 0 | -0.09 | 0 | 0.06 |
| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 |
| Reserves and Surplus | -5.69 | -1.43 | -8.07 | -1.87 | -3.41 |
| Total Shareholders Funds | 37.49 | 41.75 | 35.11 | 41.31 | 39.77 |
| Secured Loans | 0 | 0.06 | 9.42 | -8.84 | -1.13 |
| Unsecured Loans | 3.38 | 3.01 | 3.41 | 3.32 | 2.99 |
| Total Debt | 3.38 | 3.07 | 12.83 | -5.52 | 1.86 |
| Total Liabilities | 40.87 | 44.82 | 47.94 | 35.79 | 41.63 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 5.94 | 5.94 | 5.5 | 45.21 | 45.03 |
| Less: Accum. Depreciation | 0.99 | 0.58 | 0 | 39.16 | 38.26 |
| Net Block | 4.95 | 5.36 | 5.5 | 6.05 | 6.77 |
| Capital Work in Progress | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Current Assets, Loans and Advances | |||||
| Inventories | 1.72 | 0.37 | 22.47 | 25.65 | 29.89 |
| Sundry Debtors | 15.94 | 6.45 | 13.08 | 13.7 | 26.2 |
| Cash and Bank Balance | 20 | 39.05 | 20.14 | 30.26 | 23.38 |
| Loans and Advances | 10.79 | 7.61 | 6.97 | 4.39 | 4.98 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 12.02 | 12.24 | 20.32 | 43.93 | 47.32 |
| Provisions | 0.73 | 2.01 | 0.13 | 0.54 | 2.48 |
| Net Current Assets | 35.7 | 39.23 | 42.21 | 29.53 | 34.65 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 40.87 | 44.81 | 47.93 | 35.8 | 41.64 |
| Contingent Liabilities | 3.96 | 4.35 | 0 | 7.43 | 7.21 |
If I had made LUMPSUM investment of ₹ 1,00,000
in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
